Clinical Pathogenesis, Molecular Mechanisms of Gastric Cancer Development
Current Topics in Microbiology and Immunology · 2023
DOI: 10.1007/978-3-031-47331-9_2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Topics in Microbiology and Immunology, 2023. Verfasst von Lydia E Wroblewski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Stomach Neoplasms, Epstein-Barr Virus Infections, Helicobacter pylori. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
The human pathogen Helicobacter pylori is the strongest known risk factor for gastric disease and cancer, and gastric cancer remains a leading cause of cancer-related death across the globe. Carcinogenic mechanisms associated with H. pylori are multifactorial and are driven by bacterial virulence constituents, host immune responses, environmental factors such as iron and salt, and the microbiota. Infection with strains that harbor the cytotoxin-associated genes (cag) pathogenicity island, which encodes a type IV secretion system (T4SS) confer increased risk for developing more severe gastric diseases. Other important H. pylori virulence factors that augment disease progression include vacuolating cytotoxin A (VacA), specifically type s1m1 vacA alleles, serine protease HtrA, and the outer-membrane adhesins HopQ, BabA, SabA and OipA. Additional risk factors for gastric cancer include dietary factors such as diets that are high in salt or low in iron, H. pylori-induced perturbations of the gastric microbiome, host genetic polymorphisms, and infection with Epstein-Barr virus. This chapter discusses in detail host factors and how H. pylori virulence factors augment the risk of developing gastric cancer in human patients as well as how the Mongolian gerbil model has been used to define mechanisms of H. pylori-induced inflammation and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. richard.peek@vumc.org.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Wroblewski, L. E., & Peek, R. M. (2023). Clinical Pathogenesis, Molecular Mechanisms of Gastric Cancer Development. Current Topics in Microbiology and Immunology. https://doi.org/10.1007/978-3-031-47331-9_2
Vancouver
Wroblewski LE, Peek RM. Clinical Pathogenesis, Molecular Mechanisms of Gastric Cancer Development. Current Topics in Microbiology and Immunology. 2023. doi:10.1007/978-3-031-47331-9_2
BibTeX
@article{Wroblewski2023,
author = {Wroblewski, Lydia E and Peek, Richard M},
title = {Clinical Pathogenesis, Molecular Mechanisms of Gastric Cancer Development},
journal = {Current Topics in Microbiology and Immunology},
year = {2023},
doi = {10.1007/978-3-031-47331-9_2}
}
EUVIMED